Conduct disorder

Du[ko Fidanovski
46. Corbet A, Long W, Schumacher R, Gerdis J, Cotton R. Double-blind
devolepmantal evaluation ot 1-year corrected age of 597 premature infants
with birth weight from 500-1350 grams enrolled in three placebo-controlled
trials of prophylactic synthetic surfactant. American Exosurf Neonatal Study
Group I. J Pediatr, 1995;126(5pt 2):S5-S12.
47. Pelkonen AS, Hakulinen AL, Turpeinen M, Hallman M. Effect of neonatal
surfactant tharpy on lung function at school age in children born very
preterm. Pediatr Pulmonol, 1998;25(3):182-190.
48. Watterberg KL, Gerdes JS, Cook KL. Imaired glucocorticoid synthesis in
premature infants developing chronic lung disease. Pedistr Res 2001;50:190-
5.
49. Eichenwald EC, Stark AR. Are postnatal steroids ever justified to treat severe
bronchopulmonary dysplasia? Arch Dis Child Fetal Neonatal Ed,
2007;92:F334-F337.
50. Shinwell ES. Current dilemmas in postnatal steroid therapy for cronic lung
disease in preterm infants. Biol Neonate, 2003;84:23-27
51. American Academy of Pediatrics Committee on Fetus and Newborn: Postnatal
corticosteroids to trett or prevent chronic lung disease in preterm infants.
Pediatrics, 2002;109:330-338.
52. Watterberg KL, Gerdes JS, Cole CH et al. Prophylaxis of early adrenal
insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial.
Pediatrics, 2004;114:1649-57.
53. Bancalari E, Claure N, Gonzales A. Patient ductus arteriosus and respiratory
outcome in premature infants. Biol Neonate 2005;88:192-201.
54. Knight DB. The tretment of patent ductus arteriosus in preterm infants. A
review and overview of randomized trials. Semin Neonatol. 2001;(6):63-73.
55. Ohlsson A, Walis R, Shah S. Iboprofen for treatment of patent ductus
arteriosus in preterm and/or low birth weight infants. Cochrane Database
Syst Rev. 2005;(4):CD003481.
56. Schmidt E, Devis P, Moddemann D et all. Long term effects of indomethacin
prophylacsis in extremly-low-bith weight infants. N Engl J Med,
2001;334:1966-72.
57. Kabra NS, Schmidt B, Roberts RS et al. Neurosensory impairment after
surgical closure of patent ductus arteriosus in extremly low birth weight
infants: results from the Trial of Indometacin Proiphylaxis in Preterms (TIPP).
J Pediatr, 2007;150:229-34.
58. Lorenz JM. Fluid and electrolyte therapy and chronic lung disease. Curr Opin
Pediatr. 2004;16(2):152-6.
59. Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing
morbidity and mortality in preterm infants. Cochrane Database System Rev.
2001;(3):CD000503.
Страна 148